Investigation of porcine circovirus type 2 and porcine circovirus type 3 infections based on dual TaqMan fluorescent quantitative PCR method and genetic evolutionary analysis of these two viruses

Mengxiang Cao, Yanwu Wei, Weilin Shi, Li Feng, Liping HuangFrontiers in Microbiology 2024 · DOI

TL;DR

Researchers have developed a highly sensitive dual TaqMan qPCR assay to simultaneously track Porcine Circovirus types 2 (PCV2) and 3 (PCV3). Their large-scale surveillance across 15 Chinese provinces reveals that while PCV2 remains the dominant threat (especially the PCV2d genotype), the newer PCV3 is widespread and shows a concerningly high prevalence in stillborn cases.

What Problem Does This Paper Address?

Porcine circoviruses are a major headache for the global swine industry. PCV2 is a well-known pathogen causing wasting syndromes and reproductive failure. PCV3, however, is a relatively "new kid on the block," discovered in 2016. While it’s associated with similar clinical signs, its actual pathogenicity remains controversial.

The challenge for veterinarians and researchers is two-fold:

  1. Detection: Standard PCR tests often look for one virus at a time, which is inefficient given that coinfections are common.
  2. Evolution: These viruses mutate. We need to know which genotypes are currently circulating to ensure vaccines and diagnostic tools remain effective.

Methods

The authors took a multi-pronged approach:

  • Dual TaqMan qPCR: They engineered a "one-pot" quantitative PCR reaction using two different fluorescent probes (FAM for PCV2 and VIC for PCV3). This allows for the simultaneous detection and quantification of both viral loads in a single sample.
  • Epidemiological Survey: They tested 1,385 clinical samples (serum and various organs) collected between 2020 and 2023 across 15 provinces in China.
  • Genetic Sequencing & Bioinformatics: They sequenced 18 full PCV3 genomes and 64 PCV2 genomes. They used phylogenetic trees to classify genotypes and performed "selection pressure analysis" to see which parts of the viral proteins (specifically the Cap or capsid protein) are mutating to dodge the pig's immune system.

Datasets

  • Clinical Samples: 1,385 total samples (767 serum, 618 organ samples) from healthy and diseased pigs.
  • Reference Sequences: Genomic data pulled from GenBank to compare the new Chinese isolates against global strains.
  • New Sequences: 82 newly sequenced genomes (accession numbers PP179064–PP179163) were contributed to the scientific community.

Key Insights and Ideas

  • PCV2d is the New King: The study confirms a "genotype shift." While PCV2a and PCV2b used to be common, PCV2d now accounts for 62.5% of cases, likely because it is better at escaping current vaccine-induced immunity.
  • PCV3’s "Stillborn" Connection: While PCV3 viral loads were similar in healthy vs. diseased pigs, the positive rate was highest in stillborn fetuses. This suggests PCV3 might be more specifically a reproductive pathogen rather than a general systemic one.
  • Conservation vs. Chaos: PCV3 is remarkably stable (over 97% identity across regions), whereas PCV2 is a "shape-shifter" with high mutation rates in its Cap protein. This suggests that a single PCV3 vaccine might be more broadly effective than current PCV2 vaccines.
  • The "Cap" Protein Clues: The researchers identified specific amino acid sites (like 121, 191, and 206 in PCV2) that are under positive selection, meaning the virus is actively evolving at these spots to survive.

Key Results

  • Assay Performance: The dual qPCR was highly sensitive, detecting as few as 50 copies/μL for both viruses.
  • Prevalence:
    • PCV2: 57.95% positive rate.
  • PCV3: 37.47% positive rate.
  • Coinfection: 25.49% of pigs were carrying both viruses.
  • Viral Load: PCV2 viral loads were significantly higher in diseased pigs than healthy ones, confirming its clear role in illness. For PCV3, the rate of infection was higher in diseased pigs (55.69% vs 15.05%), but the actual amount of virus per gram of tissue didn't differ significantly between the two groups.

Limitations and Future Work

The authors acknowledge that the pathogenicity of PCV3 is still a bit of a mystery. While they found it frequently in diseased pigs and stillborns, they couldn't definitively prove it caused the disease without controlled infection experiments.

Additionally, they noted that PCV3 genotyping standards are still inconsistent in the literature. Future work will likely focus on refining these classification systems and developing a commercial vaccine for PCV3, as none currently exists despite its high prevalence.

Summary updated

Abstract

These results clarify the prevalence and variations of PCV2 and PCV3 in healthy and diseased pigs, which will provide a basis for the prevention and control of the two viral infections.
BibTeX
@inproceedings{cao2024investigation,
  author = {Mengxiang Cao and Yanwu Wei and Weilin Shi and Li Feng and Liping Huang},
  title = {{Investigation of porcine circovirus type 2 and porcine circovirus type 3 infections based on dual TaqMan fluorescent quantitative PCR method and genetic evolutionary analysis of these two viruses}},
  booktitle = {Frontiers in Microbiology},
  year = {2024},
  doi = {10.3389/fmicb.2024.1385137},
}
Figure